Aim: To assess the relation between islet cell antibody (ICA) positivity and demographic characteristics in an extensive series of first-degree relatives of children with type 1 diabetes (T1D). Methods: Family members of children diagnosed with T1D before the age of 16 years and attending one of 27 participating paediatric units in Finland taking care of children with diabetes were invited to volunteer for an ICA screening program aimed at identifying individuals eligible for inclusion in the European Nicotinamide Diabetes Intervention Trial (ENDIT). The final series comprised 2,522 first-degree relatives (1,107 males) with a mean age of 20.4 (range 0.1–51.9) years, out of whom 390 were fathers, 622 mothers, 717 brothers, and 793 sisters of affected cases. Results: Two hundred and four family members (8.1%) tested positive for ICA with levels ranging from 3 to 564 (median 18) Juvenile Diabetes Foundation (JDF) units. One hundred and five relatives (4.2%) had an ICA level of 18 JDF units or more. Males had detectable ICA more often than females (9.6 vs. 6.9%; p = 0.02). Antibody-positive family members under the age of 20 years had higher ICA levels than the older ones [median 18 (range 3–514) JDF units vs. 10 (range 3–564) JDF units; p = 0.008]. Among the adult relatives (≧20 years of age) antibody-positive females had higher ICA levels than the males [median 10 (range 5–564) JDF units vs. 9 (range 3–130) JDF units; p = 0.04]. Siblings had an increased frequency of high-titre ICA (≧18 JDF units) when compared to the parents (4.8 vs. 3.2%; p = 0.05). Among siblings, we found a higher frequency of ICA positivity in brothers than in sisters (10.8 vs. 6.9%; p = 0.01), and this was also true for high-titre ICA (6.0 vs. 3.8 %; p = 0.04). Geographically, the highest ICA prevalence was seen among relatives living in the middle of Finland (10.4 vs. 7.2% in the other parts of Finland; p = 0.01). Conclusions: These results imply that male gender and young age favour positive ICA reactivity among family members of children with T1D. Siblings test positive for high ICA titres (≧18 JDF units) more frequently than parents. Accordingly, judged from demographic characteristics, the yield of ICA screening in first-degree relatives would be maximized by targeting young brothers of affected cases.

Keywords:
Type 1 diabetes, Gender, First-degree relatives, Islet cell antibodies, Prediction, type 1 diabetes mellitus
1.
Atkinson MA, Maclaren NK: The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 1994;331:1428–1436.
2.
Knip M: Disease-associated autoimmunity and prevention of insulin-dependent diabetes mellitus. Ann Med 1997;29:447–451.
3.
Savola K, Läärä E, Vähäsalo P, Kulmala P, Åkerblom HK, Knip M, the Childhood Diabetes in Finland Study Group: Dynamic pattern of disease-associated autoantibodies in siblings of children with type 1 diabetes – a population-based study. Diabetes 2001;50:2625–2632.
4.
Yu L, Rewers M, Gianani R, Kawasaki E, Zhang Y, Verge C, Chase P, Klingensmith G, Erlich H, Norris J, Eisenbarth GS: Antiislet autoantibodies usually develop sequentially rather than simultaneously. J Clin Endocrinol Metab 1996;81:4264–4267.
5.
Srikanta S, Ganda OP, Rabizadeh A, Soeldner JS, Eisenbarth GS: First-degree relatives of patients with type 1 diabetes mellitus: Islet cell antibodies and abnormal insulin secretion. N Engl J Med 1985;313:461–464.
6.
Tarn AC, Thomas JM, Dean BM, Ingram G, Schwartz G, Bottazzo GF, Gale EA: Predicting insulin-dependent diabetes. Lancet 1988;i:845–850.
7.
Bonifacio E, Bingley PJ, Shattock M, Dean BM, Dunger D, Gale EA, Bottazzo GF: Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 1990;335:147–149.
8.
Riley WJ, Maclaren NK, Krischer J, Spillar RP, Silverstein JH, Schatz DA, Schwartz S, Malone J, Shah S, Vadheim C, Rotter JI: A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med 1990;323:1167–1172.
9.
Karjalainen J, Vähäsalo P, Knip M, Tuomilehto-Wolf E, Virtala E, Åkerblom HK, the Childhood Diabetes in Finland Study Group: Islet cell autoimmunity and progression to IDDM in genetically high- and low-risk siblings of diabetic children. Eur J Clin Invest 1996;26:640–649.
10.
Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, Paquette TL: Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983;222:1337–1339.
11.
Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, De Camilli P: Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990;347:151–156.
12.
Lan MS, Lu J, Goto Y, Notkins AL: Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol 1994;13:505–514.
13.
Bingley PJ, Bonifacio E, Gale EA: Can we really predict IDDM? Diabetes 1993;42:213–220.
14.
Knip M, Åkerblom HK: IDDM prevention trials in progress – a critical assessment. J Pediatr Endocrinol Metab1998;11(suppl 2): 371–377.
15.
Bottazzo GF, Florin-Christensen A, Doniach D: Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974;ii:1279–1282.
16.
Lernmark A, Molenaar JL, van Beers WA, Yamaguchi Y, Nagataki S, Ludvigsson J, Maclaren NK: The Fourth International Serum Exchange Workshop to standardize cytoplasmic islet cell antibodies. Diabetologia 1991;34:534–535.
17.
Vähäsalo P, Knip M, Karjalainen J, Tuomilehti-Wolf E, Lounamaa R, Åkerblom HK, the Childhood Diabetes in Finland Study Group: Islet cell-specific autoantibodies in children with IDDM and their siblings at clinical manifestation of the disease. Eur J Endocrinol 1996;135:689–695.
18.
McCulloch DK, Klaff LJ, Kahn SE, Schoenfeld SL, Greenbaum CJ, Mauseth RS, Benson EA, Nepom GT, Shewey L, Palmer JP: Nonprogression of subclinical beta-cell dysfunction among first-degree relatives of IDDM patients. Diabetes 1990;39:549–556.
19.
Thivolet C, Beaufrère B, Geburher L, Chatelain P, Orgiazzi J, Francois R: Autoantibodies and genetic factors associated with the development of type 1 (insulin-dependent) diabetes mellitus in first degree relatives of diabetic patients. Diabetologia 1991;34:186–191.
20.
Robert JJ, Deschamps I, Chevenne D, Roger M, Mogenet A, Boitard C: Relationship between first-phase insulin secretion and age, HLA, islet cell antibody status, and development of type 1 diabetes in 220 juvenile first-degree relatives of diabetic patients. Diabetes Care 1991;14:718–723.
21.
Gorus FK, Vandewalle CL, Dorchy H, van Crombrugge P, Schuit FC, Pipeleers DG, the Belgian Diabetes Registry: Influence of age on the associations among insulin autoantibodies, islet cell antibodies, and HLA DQA1·0301-DQB1·0302 in siblings of patients with type 1 (insulin-dependent) diabetes mellitus. J Clin Endocrinol Metab 1994;78:1172–1178.
22.
Cantor AB, Krischer JP, Cuthbertson DD, Schatz DA, Riley WJ, Malone J, Schwartz S, Quattrin T, Maclaren NK: Age and family relationship accentuate the risk of insulin-dependent diabetes mellitus (IDDM) in relatives of patients with IDDM. J Clin Endocrinol Metab 1995;80:3739–3743.
23.
Williams AJ, Bingley PJ, Moore WP, Gale EA, the ENDIT Screening Group: Islet autoantibodies, nationality and gender: A multinational screening study in first-degree relatives of patients with type I diabetes. Diabetologia 2002;45:217–223.
24.
Green A, Gale EA, Patterson CC: Incidence of childhood-onset insulin-dependent diabetes mellitus: The EURODIAB ACE Study. Lancet 1992;339:905–909.
25.
Sabbah E, Savola K, Ebeling T, Kulmala P, Vähäsalo P, Ilonen J, Salmela P, Knip M: Genetic, autoimmune, and clinical characteristics of childhood- and adult-onset type 1 diabetes mellitus. Diabetes Care 2000;23:1326–1332.
26.
Gale EA, Gillespie KM: Diabetes and gender. Diabetologia 2002;44:3–15.
27.
Weets I, Van Autreve J, Van der Auwera BJ, Schuit FC, DuCaju MV, Decochez K, De Leeuw IH, Keymeulen B, Mathieu C, Rottiers R, Dorchy H, Quertier E, Gorus FK, the Belgian Diabetes Registry: Male-to-female excess in diabetes diagnosed in early adulthood is not specific for the immune-mediated form nor is it HLA-DQ restricted: Possible relation to body mass index. Diabetologia 2001;44:40–47.
28.
Veijola R, Reijonen H, Vähäsalo P, Sabbah E, Kulmala P, Ilonen J, Åkerblom HK, Knip M, the Childhood Diabetes in Finland Study Group: HLA-DQB1-defined genetic susceptibility, beta-cell autoimmunity, and metabolic characteristics in familial and non-familial insulin-dependent diabetes mellitus. J Clin Invest 1996;98:2489–2495.
29.
Shaw C, Cruijsen H, de Beer J, de Jong A: Latest population projections for the European Union. Popul Trends 1997;90:18–30.
30.
Verge CF, Silink M, Howard NJ: The incidence of childhood IDDM in New South Wales, Australia. Diabetes Care 1994;17:693–696.
31.
Gardner SG, Bingley PJ, Sawtell PA, Weeks S, Gale EA: Rising incidence of insulin dependent diabetes in children aged under 5 years in the Oxford region: Time trend analysis. BMJ 1997;315:713–717.
32.
Verge CF, Gianini R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, Chase HP, Eisenbarth GS: Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 1996;45:926–933.
33.
Kulmala P, Savola K, Petersen JS, Vähäsalo P, Karjalainen J, Löppönen T, Dyrberg T, Åkerblom HK, Knip M, the Childhood Diabetes in Finland Study Group: Prediction of insulin-dependent diabetes mellitus in siblings of diabetic children – a population-based study. J Clin Invest 1998;101:327–336.
34.
Wagener DK, Sacks JM, LaPorte R, MacGregor JM: The Pittsburgh study of insulin-dependent diabetes mellitus: Risk for diabetes among relatives of IDDM. Diabetes 1982;31:136–144.
35.
Tillil H, Köbberling J: Age-corrected empirical genetic risk estimates for first degree relatives of IDDM patients. Diabetes 1987;36:93–99.
36.
Lorenzen T, Pociot F, Hougaard P, Nerup J: Long-term risk of IDDM in first-degree relatives of patients with IDDM. Diabetologia 1994;37:321–327.
37.
Bingley PJ, Christie MR, Bonifacio E, Bonfanti R, Shattock M, Fonte MT, Bottazzo GF, Gale EA: Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 1994;43:1304–1310.
38.
Korhonen S, Knip MM, Kulmala P, Savola K, Åkerblom HK, Knip M: Autoantibodies to GAD, IA-2 and insulin in ICA-positive first-degree relatives of children with type 1 diabetes: A comparison between parents and siblings. Diabetes Metab Res Rev 2002;18:43–48.
© 2003 S. Karger AG, Basel
2003
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.